Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ganglioneuroblastoma × fludarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 42 Precursor Cell Lymphoblastic Leukemia-Lymphoma 29 Myelodysplastic Syndromes 25 Lymphoma, Non-Hodgkin 20 Multiple Myeloma 19 Hematologic Neoplasms 19 Lymphoma 18 Lymphoma, B-Cell 15 Recurrence 14 Lymphoma, Large B-Cell, Diffuse 14 Leukemia, Lymphocytic, Chronic, B-Cell 13 Burkitt Lymphoma 13 Lymphoma, Follicular 11 Breast Neoplasms 11 Pancreatic Neoplasms 10 Myeloproliferative Disorders 9 Melanoma 9 Ovarian Neoplasms 8 Neoplasm Metastasis 8 Lymphoma, Mantle-Cell 8 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Myelomonocytic, Chronic 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia, Biphenotypic, Acute 7 Carcinoma, Non-Small-Cell Lung 7 Stomach Neoplasms 6 Leukemia 6 Hodgkin Disease 6 Colorectal Neoplasms 6 Carcinoma, Hepatocellular 6

Interventions

dinutuximab 3 Cyclophosphamide 3 Vincristine 2 Topotecan 2 Thiotepa 2 Temozolomide 2 Stem Cell Transplantation 2 Specimen Handling 2 Radiation 2 Platinum 2 Melphalan 2 Magnetic Resonance Spectroscopy 2 Isotretinoin 2 Irinotecan 2 Doxorubicin 2 Cisplatin 2 Carboplatin 2 Biopsy 2 1,2-diaminocyclohexaneplatinum II citrate 2 sargramostim 1 lorlatinib 1 fludarabine 1 etoposide phosphate 1 Transurethral Resection of Bladder 1 Razoxane 1 Radiotherapy 1 Proton Therapy 1 Nuclear Medicine Department, Hospital 1 Leukapheresis 1 Influenza Vaccines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07502287 2026-03-30

DUAL-NK-NB

Beijing Biotech

Phase 1/2 Recruiting

Neuroblastoma, Recurrence, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡